TY - JOUR AU - Neller, M. A. AU - Lopez, J. A. AU - Schmidt, C. W. PY - 2008 DA - 2008// TI - Antigens for cancer immunotherapy JO - Semin Immunol VL - 20 UR - https://doi.org/10.1016/j.smim.2008.09.006 DO - 10.1016/j.smim.2008.09.006 ID - Neller2008 ER - TY - JOUR AU - Barrett, A. J. AU - Rezvani, K. PY - 2007 DA - 2007// TI - Translational mini-review series on vaccines: peptide vaccines for myeloid leukaemias JO - Clin Exp Immunol VL - 148 UR - https://doi.org/10.1111/j.1365-2249.2007.03383.x DO - 10.1111/j.1365-2249.2007.03383.x ID - Barrett2007 ER - TY - JOUR AU - Maurer, U. AU - Brieger, J. AU - Weidmann, E. AU - Mitrou, P. S. AU - Hoelzer, D. AU - Bergmann, L. PY - 1997 DA - 1997// TI - The Wilms’ tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro JO - Exp Hematol VL - 25 ID - Maurer1997 ER - TY - JOUR AU - Algar, E. M. AU - Khromykh, T. AU - Smith, S. I. AU - Blackburn, D. M. AU - Bryson, G. J. AU - Smith, P. J. PY - 1996 DA - 1996// TI - A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines JO - Oncogene VL - 12 ID - Algar1996 ER - TY - JOUR AU - Yamagami, T. AU - Sugiyama, H. AU - Inoue, K. PY - 1996 DA - 1996// TI - Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis JO - Blood VL - 87 ID - Yamagami1996 ER - TY - JOUR AU - Nishida, S. AU - Hosen, N. AU - Shirakata, T. PY - 2006 DA - 2006// TI - AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1 JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-04-1656 DO - 10.1182/blood-2005-04-1656 ID - Nishida2006 ER - TY - JOUR AU - Cilloni, D. AU - Gottardi, E. AU - Messa, F. PY - 2003 DA - 2003// TI - Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.10.503 DO - 10.1200/JCO.2003.10.503 ID - Cilloni2003 ER - TY - JOUR AU - Cilloni, D. AU - Gottardi, E. AU - Micheli, D. PY - 2002 DA - 2002// TI - Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients JO - Leukemia VL - 16 UR - https://doi.org/10.1038/sj.leu.2402675 DO - 10.1038/sj.leu.2402675 ID - Cilloni2002 ER - TY - JOUR AU - Keilholz, U. AU - Letsch, A. AU - Busse, A. PY - 2009 DA - 2009// TI - A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2009-02-202598 DO - 10.1182/blood-2009-02-202598 ID - Keilholz2009 ER - TY - JOUR AU - Oka, Y. AU - Tsuboi, A. AU - Taguchi, T. PY - 2004 DA - 2004// TI - Induction of WT1 (Wilms’ tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression JO - Proc Natl Acad Sci USA VL - 101 UR - https://doi.org/10.1073/pnas.0405884101 DO - 10.1073/pnas.0405884101 ID - Oka2004 ER - TY - JOUR AU - Rezvani, K. AU - Yong, A. S. AU - Mielke, S. PY - 2008 DA - 2008// TI - Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-08-108241 DO - 10.1182/blood-2007-08-108241 ID - Rezvani2008 ER - TY - JOUR AU - Mailander, V. AU - Scheibenbogen, C. AU - Thiel, E. AU - Letsch, A. AU - Blau, I. W. AU - Keilholz, U. PY - 2004 DA - 2004// TI - Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity JO - Leukemia VL - 18 UR - https://doi.org/10.1038/sj.leu.2403186 DO - 10.1038/sj.leu.2403186 ID - Mailander2004 ER - TY - JOUR AU - Hashii, Y. AU - Sato-Miyashita, E. AU - Matsumura, R. PY - 2012 DA - 2012// TI - WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.226 DO - 10.1038/leu.2011.226 ID - Hashii2012 ER - TY - JOUR AU - Stasi, A. AU - Jimenez, A. M. AU - Minagawa, K. AU - Al-Obaidi, M. AU - Rezvani, K. PY - 2015 DA - 2015// TI - Review of the results of WT1 peptide vaccination strategies for myelodysplastic syndromes and acute myeloid leukemia from nine different studies JO - Front Immunol VL - 6 UR - https://doi.org/10.3389/fimmu.2015.00036 DO - 10.3389/fimmu.2015.00036 ID - Stasi2015 ER - TY - JOUR AU - Salem, M. L. AU - Kadima, A. N. AU - Cole, D. J. AU - Gillanders, W. E. PY - 2005 DA - 2005// TI - Defining the antigen-specific T-cell response to vaccination and poly (I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity JO - J Immunother VL - 28 UR - https://doi.org/10.1097/01.cji.0000156828.75196.0d DO - 10.1097/01.cji.0000156828.75196.0d ID - Salem2005 ER - TY - JOUR AU - Lacour, J. AU - Lacour, F. AU - Spira, A. PY - 1980 DA - 1980// TI - Adjuvant treatment with polyadenylic–polyuridylic acid (Polya. Polyu) in operable breast cancer JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(80)90057-4 DO - 10.1016/S0140-6736(80)90057-4 ID - Lacour1980 ER - TY - JOUR AU - Khan, A. L. AU - Heys, S. D. AU - Eremin, O. PY - 1995 DA - 1995// TI - Synthetic polyribonucleotides: current role and potential use in oncological practice JO - Eur J Surg Oncol VL - 21 UR - https://doi.org/10.1016/S0748-7983(95)90930-3 DO - 10.1016/S0748-7983(95)90930-3 ID - Khan1995 ER - TY - JOUR AU - Inoue, H. AU - Park, J. H. AU - Kiyotani, K. PY - 2016 DA - 2016// TI - Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1204507 DO - 10.1080/2162402X.2016.1204507 ID - Inoue2016 ER - TY - JOUR AU - Rezvani, K. AU - Brenchley, J. M. AU - Price, D. A. PY - 2005 DA - 2005// TI - T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms’ tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-1314 DO - 10.1158/1078-0432.CCR-05-1314 ID - Rezvani2005 ER - TY - JOUR AU - Rezvani, K. AU - Yong, A. S. AU - Mielke, S. PY - 2011 DA - 2011// TI - Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2010.031674 DO - 10.3324/haematol.2010.031674 ID - Rezvani2011 ER - TY - JOUR AU - Kawai, T. AU - Akira, S. PY - 2006 DA - 2006// TI - TLR signaling JO - Cell Death Differ VL - 13 UR - https://doi.org/10.1038/sj.cdd.4401850 DO - 10.1038/sj.cdd.4401850 ID - Kawai2006 ER - TY - JOUR AU - Pasare, C. AU - Medzhitov, R. PY - 2003 DA - 2003// TI - Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells JO - Science VL - 299 UR - https://doi.org/10.1126/science.1078231 DO - 10.1126/science.1078231 ID - Pasare2003 ER - TY - JOUR AU - Salazar, A. M. AU - Levy, H. B. AU - Ondra, S. PY - 1996 DA - 1996// TI - Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic–polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study JO - Neurosurgery VL - 38 UR - https://doi.org/10.1227/00006123-199606000-00006 DO - 10.1227/00006123-199606000-00006 ID - Salazar1996 ER - TY - JOUR AU - Rosenfeld, M. R. AU - Chamberlain, M. C. AU - Grossman, S. A. PY - 2010 DA - 2010// TI - A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma JO - Neuro-Oncology VL - 12 UR - https://doi.org/10.1093/neuonc/noq071 DO - 10.1093/neuonc/noq071 ID - Rosenfeld2010 ER - TY - JOUR AU - Sabbatini, P. AU - Tsuji, T. AU - Ferran, L. PY - 2012 DA - 2012// TI - Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-2189 DO - 10.1158/1078-0432.CCR-12-2189 ID - Sabbatini2012 ER - TY - JOUR AU - Rapoport, A. P. AU - Aqui, N. A. AU - Stadtmauer, E. A. PY - 2014 DA - 2014// TI - Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2817 DO - 10.1158/1078-0432.CCR-13-2817 ID - Rapoport2014 ER - TY - JOUR AU - Tanaka-Harada, Y. AU - Kawakami, M. AU - Oka, Y. PY - 2010 DA - 2010// TI - Biased usage of BV gene families of T-cell receptors of WT1 (Wilms’ tumor gene)-specific CD8+ T cells in patients with myeloid malignancies JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2009.01453.x DO - 10.1111/j.1349-7006.2009.01453.x ID - Tanaka-Harada2010 ER - TY - JOUR AU - Ochsenreither, S. AU - Fusi, A. AU - Geikowski, A. PY - 2012 DA - 2012// TI - Wilms’ tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3beta sequence associated with remission in one patient is detectable in other vaccinated patients JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1099-y DO - 10.1007/s00262-011-1099-y ID - Ochsenreither2012 ER - TY - JOUR AU - Stauss, H. J. AU - Thomas, S. AU - Cesco-Gaspere, M. PY - 2008 DA - 2008// TI - WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells JO - Blood Cells Mol Dis VL - 40 UR - https://doi.org/10.1016/j.bcmd.2007.06.018 DO - 10.1016/j.bcmd.2007.06.018 ID - Stauss2008 ER - TY - JOUR AU - Xue, S. A. AU - Gao, L. AU - Hart, D. PY - 2005 DA - 2005// TI - Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-01-0146 DO - 10.1182/blood-2005-01-0146 ID - Xue2005 ER - TY - JOUR AU - Chapuis, A. G. AU - Ragnarsson, G. B. AU - Nguyen, H. N. PY - 2013 DA - 2013// TI - Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3004916 DO - 10.1126/scitranslmed.3004916 ID - Chapuis2013 ER -